DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post 
Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates 
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi 
Nissan Halts Electric Qashqai Development Amid EV Market Challenges 
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 
KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
FedEx Stock Drops After Weak 2026 Earnings Forecast Despite Strong Q4 Results 
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test 
Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites 
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast 
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White 
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates 
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence 
SANTA BARBARA, Calif., Feb. 23, 2016 -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that the Company will release its fourth quarter and full year 2015 financial results on Wednesday, March 9, 2016 after the market close.
Sientra will hold a conference call on Wednesday, March 9, 2016 at 1:30 p.m. PT/4:30 p.m. ET to discuss the results. The dial-in numbers are (844) 464-3933 for domestic callers and (765) 507-2612 for international callers. The conference ID is 49938904. A live webcast of the conference call will be available on the Investor Relations section of the Company's website at www.sientra.com.
A replay of the call will be available starting on March 9, 2016 at 4:30 p.m. PT/7:30 p.m. ET, through March 10, 2016 at 8:59 p.m. PT/11:59 p.m. ET. To access the replay, dial (855) 859-2056 for domestic callers and (404) 537-3406 for international callers, and use the replay conference ID 49938904. The webcast will be available on the Investor Relations section of the Company’s website for 30 days following the completion of the call.
About Sientra
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company committed to making a difference in patients’ lives by enhancing their body image, growing their self-esteem and restoring their confidence. The Company was founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The Company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants and breast tissue expanders exclusively to board-certified and board-admissible plastic surgeons and tailors its customer service offerings to their specific needs. The Company also offers a range of other aesthetic and specialty products.
Investor Contacts: The Ruth Group Nick Laudico (646) 536-7030 [email protected]
